C M Marra
Overview
Explore the profile of C M Marra including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
46
Citations
4336
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kallianpur A, Gittleman H, Letendre S, Ellis R, Barnholtz-Sloan J, Bush W, et al.
Mol Neurobiol
. 2018 Sep;
56(5):3808-3818.
PMID: 30209774
Dysregulated iron transport and a compromised blood-brain barrier are implicated in HIV-associated neurocognitive disorders (HAND). We quantified the levels of proteins involved in iron transport and/or angiogenesis-ceruloplasmin, haptoglobin, and vascular...
2.
Robertson K, Jiang H, Evans S, Marra C, Berzins B, Hakim J, et al.
J Neurovirol
. 2016 Jan;
22(4):472-8.
PMID: 26733457
Infrastructure for conducting neurological research in resource-limited settings (RLS) is limited. The lack of neurological and neuropsychological (NP) assessment and normative data needed for clinical interpretation impedes research and clinical...
3.
Marra C, Deutsch R, Collier A, Morgello S, Letendre S, Clifford D, et al.
Int J STD AIDS
. 2013 Aug;
24(5):351-5.
PMID: 23970701
Cognitive impairment is common in HIV-infected individuals, as is syphilis. Treponema pallidum, the bacterium that causes syphilis, invades the central nervous system early in disease. We hypothesized that HIV-infected patients...
4.
Morgan E, Woods S, Letendre S, Franklin D, Bloss C, Goate A, et al.
J Neurovirol
. 2013 Feb;
19(2):150-6.
PMID: 23408335
This is a cross-sectional, observational study to evaluate the hypothesis that HIV-seropositive (HIV+) apolipoprotein E4 (APOE4) carriers are at increased risk for HIV-associated neurocognitive disorders (HAND) compared to APOE4 noncarriers...
5.
Blackstone K, Moore D, Franklin D, Clifford D, Collier A, Marra C, et al.
Clin Neuropsychol
. 2012 Jun;
26(6):894-908.
PMID: 22708483
Because HIV-related neurocognitive impairment is usually mild and variable, clinical ratings (CR) and global deficit scores (GDS) are recommended for detecting HIV-associated neurocognitive disorders (HAND). The CR approach requires impairment...
6.
Robertson K, Jiang H, Kumwenda J, Supparatpinyo K, Evans S, Campbell T, et al.
Clin Infect Dis
. 2012 Jun;
55(6):868-76.
PMID: 22661489
Background: AIDS Clinical Trials Group (ACTG) A5199 compared the neurological and neuropsychological (NP) effects of 3 antiretroviral regimens in participants infected with human immunodeficiency virus type 1 (HIV-1) in resource-limited...
7.
Blackstone K, Moore D, Heaton R, Franklin Jr D, Woods S, Clifford D, et al.
J Int Neuropsychol Soc
. 2011 Nov;
18(1):79-88.
PMID: 22114912
Three types of HIV-associated neurocognitive disorders (HAND) exist that are distinguished by presence and severity of impairment in cognitive and everyday functioning. Although well-validated neurocognitive measures exist, determining impairment in...
8.
Heaton R, Clifford D, Franklin Jr D, Woods S, Ake C, Vaida F, et al.
Neurology
. 2010 Dec;
75(23):2087-96.
PMID: 21135382
Objectives: This is a cross-sectional, observational study to determine the frequency and associated features of HIV-associated neurocognitive disorders (HAND) in a large, diverse sample of infected individuals in the era...
9.
Robinson-Papp J, Morgello S, Vaida F, Fitzsimons C, Simpson D, Elliott K, et al.
Pain
. 2010 Sep;
151(3):732-736.
PMID: 20851521
Sensory neuropathy (HIV-SN) is a common cause of pain in HIV-infected people. Establishing a diagnosis of HIV-SN is important, especially when contemplating opioid use in high-risk populations. However physical findings...
10.
Schifitto G, Yiannoutsos C, Ernst T, Navia B, Nath A, Sacktor N, et al.
Neurology
. 2009 Nov;
73(23):1975-81.
PMID: 19890073
Objective: To assess the effectiveness of the selegiline transdermal system (STS) in reversing HIV-induced metabolic brain injury (as measured by proton magnetic resonance spectroscopy [MRS]) and in decreasing oxidative stress,...